Rafał Watrowski

Dr. Rafał Watrowski

University of Freiburg, Freiburg im Breisgau, Baden-Württemberg, Germany
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2005 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
NCNicole Concin
Nicole Concin
GHGerda Hofstetter
Gerda Hofstetter
ABAstrid Berger
Astrid Berger
AGAdriana Gehmacher
Adriana Gehmacher
DRDaniel Reimer
Daniel Reimer
Robert ZeillingerRobert Zeillinger
Robert Zeillinger
Purpose: We aimed to determine the clinical role of the p53 family members p53 and p73 in the responsiveness to platinum-based chemotherapy and survival in ovarian cancer, considering their cross-talk and the p53 polymorphism at codon 72. Experimental Design: A detailed analysis of p53 and p73 in a series of 122 ovarian cancers was done. We used a functional yeast-based assay to determine the p53 mutational status. Red yeast colonies, indicating mutant p53, were subsequently sequenced to determine the specific p53 alteration. p53 mutations were divided into two groups according to their previous characterization in the literature: those that efficiently inhibit transcriptionally active TAp73 function and those that do not. A p53 polymorphism at codon 72 was determined in corresponding normal tissue or blood of ovarian cancer patients. Isoform-specific p73 expression analysis using real-time reverse transcription-PCR has previously been done in the majority of ovarian cancers included in this study. In a retrospective chart review, responsiveness to chemotherapy was assessed, and survival data with long follow-up times were collected. Results: Eighty of 122 (65.6%) of ovarian cancers harbored p53 mutations. p53 mutational status was an important determinant of responsiveness to platinum-based chemotherapy in all patients with a residual tumor of <2 cm in diameter after initial surgery (wild-type versus mutant, P = 0.029). In addition, p53 mutational status was a strong prognosticator for recurrence-free and overall survival (P < 0.0001 and P = 0.003, respectively) in univariate analyses. High expression levels of dominant-negative p73 isoforms (ΔNp73 and ΔN′p73) significantly correlated with chemotherapeutic failure (P = 0.048) and with worse recurrence-free and overall survival in patients with p53 mutant cancers (P = 0.048 and P = 0.005, respectively). Eight p53 mutations, present in 19 cases, were found that efficiently inhibit TAp73 (i.e., 175H, 220C, 245S, 245D, 248W, 248Q, 266E, and 273H). Patients with p53 mutations that efficiently inhibit TAp73 function had a significantly shorter overall survival than patients with p53 mutations of unknown effect on TAp73 (P = 0.044). The p53 polymorphism at codon 72 had no influence on responsiveness to chemotherapy or survival. Conclusion: We provide the first clinical evidence that dominant-negative p73 isoforms contribute to drug resistance in vivo, underscoring the importance of a p53-p73 cross-talk. NH2-terminally truncated p73 isoforms were of significant clinical effect by providing an additional unfavorable factor for response to platinum-based chemotherapy and survival in p53 mutant ovarian cancers.

28 August 2021 in Videosurgery and Other Miniinvasive Techniques
Verified
Journal Article
Open access
RWRafał Watrowski
Rafał Watrowski
SKStoyan Kostov
Stoyan Kostov
IAIbrahim Alkatout
Ibrahim Alkatout
Almost all gynecological and general-surgical operations are – or can be – performed laparoscopically. In comparison to an abdominal approach, the minimally invasive access offers several advantages; however, laparoscopy (both conventional and robotic-assisted) can be associated with...

9 May 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
Salvatore Giovanni VitaleSalvatore Giovanni Vitale
Salvatore Giovanni Vitale
RWRafał Watrowski
Rafał Watrowski
Fabio BarraFabio Barra
Fabio Barra
Maurizio Nicola D'AlterioMaurizio Nicola D'Alterio
Maurizio Nicola D'Alterio
Jose CarugnoJose Carugno
Jose Carugno
Stefano AngioniStefano Angioni
Stefano Angioni
Abnormal uterine bleeding (AUB) is a frequent symptom in perimenopausal women. It is defined as uterine bleeding in which the duration, frequency, or amount of bleeding is considered excessive and negatively affects the woman’s quality of life (QoL) and psychological well-being. In cases of structural uterine pathology, hysterectomy (usually performed via a minimally invasive approach) offers definitive symptom relief and is associated with long-lasting improvement of QoL and sexuality. However, over the past 30 years, uterus-preserving treatments have been introduced as alternatives to hysterectomy. Hysteroscopic polypectomy, myomectomy, or endometrial resection/endometrial ablation are minimally invasive techniques that can be used as an alternative to hysterectomy to treat AUB due to benign conditions. Although associated with high patient satisfaction and short-term improvement in their QoL, hysteroscopic treatments do not eliminate the risk of AUB recurrence or the need for further intervention. Therefore, considering the impact of different treatment options on QoL and sexuality during preoperative shared decision making could help identify the most appropriate and personalized treatment options for perimenopausal women suffering from AUB.

12 August 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
VGVeronika Günther
Veronika Günther
AMAbbas Mi
Abbas Mi
RWRafal Watrowski
Rafal Watrowski
NMNicolai Maass
Nicolai Maass
JAJohannes Ackermann
Johannes Ackermann
IAIbrahim Alkatout
Ibrahim Alkatout
The human microbiome has been given increasing importance in recent years. The establishment of sequencing-based technology has made it possible to identify a large number of bacterial species that were previously beyond the scope of culture-based technologies. Just as microbiome diagnostics has emerged as a major point of focus in science, reproductive medicine has developed into a subject of avid interest, particularly with regard to causal research and treatment options for implantation failure. Thus, the vaginal microbiome is discussed as a factor influencing infertility and a promising target for treatment options. The present review provides an overview of current research concerning the impact of the vaginal microbiome on the outcome of reproductive measures. A non-Lactobacillus-dominated microbiome was shown to be associated with dysbiosis, possibly even bacterial vaginosis. This imbalance has a negative impact on implantation rates in assisted reproductive technologies and may also be responsible for habitual abortions. Screening of the microbiome in conjunction with antibiotic and/or probiotic treatment appears to be one way of improving pregnancy outcomes.

27 July 2013 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
DCDan Cacsire Castillo-Tong
Dan Cacsire Castillo-Tong
Dietmar PilsDietmar Pils
Dietmar Pils
Georg HeinzeGeorg Heinze
Georg Heinze
IBIoana Braicu
Ioana Braicu
JSJalid Sehouli
Jalid Sehouli
WRWanda F. Reynolds
Wanda F. Reynolds

1 January 2014 in Archives of Medical Science
Verified
Journal Article
Open access
RWRafał Watrowski
Rafał Watrowski
ARAnke Rohde
Anke Rohde
Introduction: We analyzed the psychometric properties of the Polish version of the Hospital Anxiety and Depression Scale (HADS) in gynecologic patients. Material and methods : A total of 252 patients, consisting of three subgroups – endocrinologic gynecology (n = 67), high-risk pregnancy...